The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Sareum Holdings plc (AIM: SAR), a biotechnology company developing next generation kinase inhibitors for autoimmune disease and cancer, announces that Dr Stephen Parker, Non-Executive Chairman, purchased 19,972 ordinary shares of 0.0125 pence each in the Company ("Ordinary Shares") at an average price of 77.6 pence per share on 28 December 2022. Shares are held in either Dr. Parker's SIPP or an ISA account.
The notification below, which has been made in accordance with the requirements of the Market Abuse Regulation, provides further details.
Following the transaction, Dr Parker has a holding in Sareum of 103,660 Ordinary Shares, from a previous holding of 83,688 Ordinary Shares.
I guess this can be classed as being slightly positive, trying to put company in shop window - Posted on LinkedIn today.
Our Chairman Stephen Parker will be attending the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, from 9-12 January.
At Sareum Ltd we are focused on advancing our internal programmes on distinct dual tyrosine kinase 2 (#TYK2) / Janus kinase 1 (#JAK1) inhibitors into clinical development as potential new therapies for autoimmune diseases, respiratory symptoms arising from viral infections and cancer immunotherapy.
Stephen would be delighted to meet anyone who would like to learn more about Sareum, so please get in contact if you would like to meet with him.
#JPM2023 #Conference #Healthcare
The BOD really need to stabilise the share price by showing confidence in SAR and buying some shares in the next couple or days. We can't afford the constant slide each day and making new lows since consolidation. Hopefully by the time the CTA is completed we will be back above 200 and looking to push on.
Management really do need to buck their ideas up and show some form of confidence to the market by the way of purchasing shares tomorrow otherwise this will free fall and what a disaster this has been since consolidation.
Does it matter? There is no volume and your clogging up the chatroom with crap about buys and sells when there has only been thus far 42,955 shares traded which in old money is just over 2m! No news days so move on.